Drug intelligence / Profile preview

Xingshen Jieyu granules

Development stage
Unknown
Lead developer
Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Xingshen Jieyu granules is a Traditional Chinese Medicine (TCM) herbal formulation developed for the treatment of post-stroke depression (PSD). Developed by the Seventh People's Hospital affiliated to Shanghai University of Traditional Chinese Medicine, the granules are designed to alleviate depressive symptoms, improve neurological function, and enhance functional outcomes in patients following a stroke. The formulation is hypothesized to exert its therapeutic effects by modulating the expression of Brain-Derived Neurotrophic Factor (BDNF) and influencing resting-state functional connectivity within the brain, as measured by fMRI. In clinical research, it is evaluated as both a monotherapy and as an adjunctive treatment alongside selective serotonin reuptake inhibitors (SSRIs) such as escitalopram.

Other names
Xingshen Jieyu DecoctionXingshen Jieyu Keli
02

Targets

BDNF (Brain-derived neurotrophic factor)

Beyond the preview

Go deeper on Xingshen Jieyu granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xingshen Jieyu granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call